Get started
Author

Mariko Nishioka

Prevalence of HER3 Expression in Pancreatic Cancer Patients Treated With Systemic Chemotherapy
2024 · Tomoyuki Satake, Chigusa Morizane, et al. · Cancer Medicine · 5
PDF
A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
2024 · MARIKO NISHIOKA, NAOHIRO OKANO, et al. · Anticancer Research · 5
P10-6 Report of a case of sigmoid colon cancer simultaneously harboring the BRAF V600E mutation and NTRK3 fusion gene
2022 · Kirio Kawai, Masato Hayashi, et al. · Annals of Oncology · 3
Systemic therapy for pretreated advanced biliary tract cancer: past developments and recent advances
2025 · Naohiro Okano, Angelo Pirozzi, et al. · Japanese Journal of Clinical Oncology · 2
Treatment outcomes by stratifying the N-acetyl transferase 2 phenotype in pre-treated patients with advanced refractory biliary tract cancer treated with nanvuranlat, an L-type amino acid transporter inhibitor: An ad-hoc analysis of a randomized, double-blind, placebo-controlled phase 2 study.
2024 · Naohiro Okano, Fumio Nagashima, et al. · Journal of Clinical Oncology · 2
HER3 expression status following systemic chemotherapy treatment in biliary tract cancers.
2023 · Mariko Nishioka, Chigusa Morizane, et al. · Journal of Clinical Oncology · 1
Time Toxicity in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine Plus Cisplatin With or Without Durvalumab
2026 · Naohiro Okano, Angelo Pirozzi, et al. · JCO oncology advances.
PDF
Two cases of metastatic colorectal cancer in which epidermal growth factor receptor gene amplification benefited from panitumumab monotherapy
2025 · Taro Sato, Fumio Nagashima, et al. · International Cancer Conference Journal
Efficacy and safety of gemcitabine plus nab-paclitaxel combination chemotherapy in patients with advanced pancreatic cancer refractory to gemcitabine monotherapy
2023 · Mariko Nishioka, Naohiro Okano, et al. · Research Square
PDF
Abstract 3405: Changes in HER3 expression associated with chemotherapy for pancreatic cancer
2023 · Tomoyuki Satake, Chigusa Morizane, et al. · Cancer Research
Abstract 4484: HER3 expression after systemic therapy and clinical characteristics in patients with hepatocellular carcinoma
2023 · Mao Okada, Chigusa Morizane, et al. · Cancer Research
胆道癌の薬物療法:Up-to-Date 切除不能胆道癌に対する二次治療-現状と今後の期待-
2018 · Okano Naohiro, Takashi Kurosawa, et al. · 胆と膵
Works count: 12
Citation count: 18
H-index: 3
I10-index:
Year
Topic
Type